ITGAV and neoplasm: The results showed that ITGAV and LOXL2 presented higher expression in tumor tissues than those in paracancerous tissues (TCGA-LIHC, https://portal.gdc.cancer.gov/projects/TCGA-LIHC) (p < 0.001, Additional file 6: Fig. S3A).